At 29.7x earnings with a Forward P/E of 14.8 and a PEG Forward of 0.9, the market is clearly pricing in a meaningful acceleration in earnings, creating a sharp valuation compression setup if EPS Next Year of $3.87 materializes. A sub‑1.0 PEG alongside 23.70% ROE and 34.80% operating margins suggests the stock is not expensive relative to its forward growth profile, even with a Price/Sales of 7.2 and a rich Price/Book of 10.3. The absence of an Altman Z-Score and Debt/Equity figure limits visibility into balance sheet risk, but the valuation spread between current and forward earnings implies the market expects normalization or expansion in profitability rather than deterioration. This is not a distressed balance sheet story — it is a multiple recalibration story hinging on execution.
